Results 171 to 180 of about 56,972 (200)
Some of the next articles are maybe not open access.
Transfusion, 2023
Adult inpatients (age ≥ 18) admitted to a large tertiary care hospital center between January 1, 2010 and December 31, 2019 and transfused at least 1 unit of plasma during admission to hospital were included.
K. Royals +4 more
semanticscholar +1 more source
Adult inpatients (age ≥ 18) admitted to a large tertiary care hospital center between January 1, 2010 and December 31, 2019 and transfused at least 1 unit of plasma during admission to hospital were included.
K. Royals +4 more
semanticscholar +1 more source
, 2021
INTRODUCTION: hemolytic disease of newborn; also known as erythroblastosis fetalis, is an preventable blood group disorder that occurs when the blood types of mother and fetus are incompatible.
D. Kaur +3 more
semanticscholar +1 more source
INTRODUCTION: hemolytic disease of newborn; also known as erythroblastosis fetalis, is an preventable blood group disorder that occurs when the blood types of mother and fetus are incompatible.
D. Kaur +3 more
semanticscholar +1 more source
Transfusion, 2023
48 patients who did not have a planned indication for LP 30 (63%) were in patients undergoing therapeutic plasma exchange procedures that infused an average of 4.5 ± 3.8 LP units per exchange.
E. Gosney, A. Mejia, A. Orbeck, A. Chen
semanticscholar +1 more source
48 patients who did not have a planned indication for LP 30 (63%) were in patients undergoing therapeutic plasma exchange procedures that infused an average of 4.5 ± 3.8 LP units per exchange.
E. Gosney, A. Mejia, A. Orbeck, A. Chen
semanticscholar +1 more source
Transfusion Medicine, 2020
Therapeutic whole blood exchange (TWBE) has been used as an alternative when methylene blue (MB) fails in severe methaemoglobinemia. However, there are limited data on the efficacy and safety of TWBE.
P. Singh +12 more
semanticscholar +1 more source
Therapeutic whole blood exchange (TWBE) has been used as an alternative when methylene blue (MB) fails in severe methaemoglobinemia. However, there are limited data on the efficacy and safety of TWBE.
P. Singh +12 more
semanticscholar +1 more source
Vox Sanguinis, 2020
Blood transfusion is the cornerstone treatment to reduce the clinical severity of sickle cell disease (SCD), but we need to maintain the haematocrit (Hct) within an acceptable range to avoid a deleterious increase in blood viscosity.
N. Ait Abdallah +12 more
semanticscholar +1 more source
Blood transfusion is the cornerstone treatment to reduce the clinical severity of sickle cell disease (SCD), but we need to maintain the haematocrit (Hct) within an acceptable range to avoid a deleterious increase in blood viscosity.
N. Ait Abdallah +12 more
semanticscholar +1 more source
[Neonatal exchange transfusion with irradiated whole blood. Preliminary results].
Archives francaises de pediatrie, 1989Some clinical manifestations following exchange transfusion (ET) could result from graft versus host disease secondary to the introduction of viable foreign T lymphocytes: skin rash, fever, acute and sometimes bloody diarrhea or enterocolitis. Between February 1985 and January 1989 the blood used for 31 ET was irradiated at 40 grays.
R, Mettey +5 more
openaire +1 more source
Singapore medical journal, 2011
Exchange transfusion is performed using many different combinations of blood components. No single component is unequivocally the best. The purpose of this study was to determine the efficacy and adverse events of exchange transfusion (ECT) with whole blood and reconstituted blood in neonatal hyperbilirubinaemia.The medical charts of all neonates who ...
M M, Gharehbaghi, S S, Hosseinpour
openaire +1 more source
Exchange transfusion is performed using many different combinations of blood components. No single component is unequivocally the best. The purpose of this study was to determine the efficacy and adverse events of exchange transfusion (ECT) with whole blood and reconstituted blood in neonatal hyperbilirubinaemia.The medical charts of all neonates who ...
M M, Gharehbaghi, S S, Hosseinpour
openaire +1 more source
Circulating tumour DNA — looking beyond the blood
Nature Reviews Clinical Oncology, 2022Ann Tivey, Matt Church, Natalie Cook
exaly
The blood–tumour barrier in cancer biology and therapy
Nature Reviews Clinical Oncology, 2021Patricia S Steeg
exaly